Fludrocortisone acetate
- CAS No.
- 514-36-3
- Chemical Name:
- Fludrocortisone acetate
- Synonyms
- 9α;U 4845;NSC 15186;cortineff;scherofluron;alfloroneacetate;Fluorocortisol acetate;FLUDROCORTISONE ACETATE;9-FLUOROCORTISOL ACETATE;9α-Fluorcortisol acetate
- CBNumber:
- CB5442481
- Molecular Formula:
- C23H31FO6
- Molecular Weight:
- 422.49
- MDL Number:
- MFCD00864160
- MOL File:
- 514-36-3.mol
| Melting point | 233-234°C |
|---|---|
| Boiling point | 575.1±50.0 °C(Predicted) |
| alpha | D23 +123° (c = 0.64 in chloroform) |
| Density | 1.0953 (rough estimate) |
| refractive index | 1.5980 (estimate) |
| storage temp. | 2-8°C |
| solubility | Practically insoluble in water, sparingly soluble in anhydrous ethanol. |
| pka | 12.06±0.70(Predicted) |
| form | Solid |
| color | White to Off-White |
| Water Solubility | 54mg/L(25 ºC) |
| InChIKey | UUHYILPJUKGJDI-XYNXPQAZSA-N |
| SMILES | F[C@]12[C@H](C[C@@]3([C@@](O)(C(=O)COC(=O)C)CC[C@@]3([H])[C@]1([H])CCC1=CC(=O)CC[C@]21C)C)O |&1:1,2,4,5,16,18,28,r| |
| CAS DataBase Reference | 514-36-3(CAS DataBase Reference) |
| FDA UNII | V47IF0PVH4 |
| NCI Drug Dictionary | fludrocortisone acetate |
| EPA Substance Registry System | Fluorocortisone acetate (514-36-3) |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |   GHS07,GHS08 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H302-H361 | |||||||||
| Precautionary statements | P280-P301+P312+P330 | |||||||||
| Hazard Codes | Xn | |||||||||
| Risk Statements | 63 | |||||||||
| Safety Statements | 22-26-36 | |||||||||
| WGK Germany | 3 | |||||||||
| RTECS | TU5050000 | |||||||||
| HS Code | 2937220000 | |||||||||
| Toxicity | LD50 oral in rat: > 1gm/kg | |||||||||
| NFPA 704 |
|
Fludrocortisone acetate price More Price(19)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | F6127 | Fludrocortisone acetate ≥98% | 514-36-3 | 1g | $95.3 | 2024-03-01 | Buy |
| Sigma-Aldrich | 1273003 | Fludrocortisone acetate United States Pharmacopeia (USP) Reference Standard | 514-36-3 | 200mg | $436 | 2024-03-01 | Buy |
| Cayman Chemical | 24032 | Fludrocortisone Acetate ≥98% | 514-36-3 | 250mg | $32 | 2024-03-01 | Buy |
| Cayman Chemical | 24032 | Fludrocortisone Acetate ≥98% | 514-36-3 | 500mg | $57 | 2024-03-01 | Buy |
| Sigma-Aldrich | F6127 | Fludrocortisone acetate ≥98% | 514-36-3 | 5g | $380 | 2024-03-01 | Buy |
Fludrocortisone acetate Chemical Properties,Uses,Production
Description
Fludrocortisone acetate is the acetate form of the synthetic corticosteroid fludrocortisone, which is a mineralocorticoid receptor agonist. Fludrocortisone acetate (0.1-5 μg/animal) promotes sodium retention in rats in a dose-dependent manner with 37% of sodium excreted compared with control when used at a dose of 5 μg/animal. Formulations containing fludrocortisone acetate have been used in the treatment of Addison’s disease.
Chemical Properties
Crystalline Solid
Originator
Alflorone Acetate,MSD,US,1954
Definition
ChEBI: An acetate ester resulting from the formal condensation of the primary hydroxy group of fludrocortisone with acetic acid. A synthetic corticosteroid, it has glucocorticoid actions about 10 times as potent as hydrocortisone, while its mineralocorticoid acti ns are over 100 times as potent. It is used in partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison's disease and for the treatment of salt-losing adrenal hyperplasia.
Manufacturing Process
Hydrocortisone acetate is first reacted with phosphorus oxychloride in pyridine to give the corresponding olefin. Then a sequence consisting of hypobromous acid addition, ring closure to the epoxide and ring opening with hydrogen fluoride gives fludrocortisone acetate. Preparation of a crystalline product is described then in US Patent 2,957,013.
brand name
Florinef (King).
Therapeutic Function
9-Fluoro-11β,17,21-trihydroxy-pregn-4-ene-3,20-dione acetate
General Description
Fludrocortisone acetate,21-acetyloxy-9-fluoro-11β,17-dihydroxypregn-4-ene-3,20-dione, 9α-fluorohydrocortisone (Florinef Acetate), isused only for the treatment of Addison disease and for inhibitionof endogenous adrenocortical secretions. It has up to about 800 times the MC activity of hydrocortisone and about 11 times the GC activity. Its potent activity stimulated the synthesis and study of the many fluorinated steroids. Although its great salt-retaining activity limits its use to Addison disease, it has sufficient GC activity that in some cases of the disease, additional GCs need not be prescribed.
Biochem/physiol Actions
Fludrocortisone acetate is a synthetic corticosteroid with more mineralocorticoid than glucocorticoid activity.
Clinical Use
Fludrocortisone acetate is mineralocorticoid. It is used as a replacement therapy in adrenal insufficiency. Fludrocortisone acetate tablets USP, 0.1 mg are indicated as partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison's disease and for the treatment of salt-losing adrenogenital syndrome. ludrocortisone is a man-made form of a natural substance (glucocorticoid) made by the body. It is used along with other medications (such as hydrocortisone) to treat low glucocorticoid levels caused by disease of the adrenal gland (such as Addison's disease, adrenocortical insufficiency, salt-losing adrenogenital syndrome). Glucocorticoids are needed in many ways for the body to function well. They are important for salt and water balance and keeping blood pressure normal. They are also needed to break down carbohydrates in your diet.
Veterinary Drugs and Treatments
Fludrocortisone is used in small animal medicine for the treatment
of adrenocortical
insufficiency (Addison’s disease). It can also be
used as adjunctive therapy in hyperkalemia.
Additionally, in humans, fludrocortisone has been used in saltlosing,
congenital adrenogenital syndrome
and in patients with severe
postural hypotension.
Drug interactions
Potentially hazardous interactions with other drugs Aldesleukin: avoid concomitant use. Antibacterials: metabolism accelerated by rifamycins; metabolism possibly inhibited by erythromycin; possibly reduce isoniazid concentration. Anticoagulants: efficacy of coumarins and phenindione may be altered. Antiepileptics: metabolism accelerated by carbamazepine, fosphenytoin, phenobarbital, phenytoin and primidone. Antifungals: increased risk of hypokalaemia with amphotericin - avoid; metabolism possibly inhibited by itraconazole and ketoconazole. Antivirals: concentration possibly increased by ritonavir. Cobicistat: concentration of fludrocortisone increased. Vaccines: high dose corticosteroids can impair immune response to vaccines - avoid concomitant use with live vaccines
Metabolism
Fludrocortisone is hydrolysed to produce the nonesterified alcohol. In human volunteers, excretion through urine was about 80%, and it was concluded that about 20% were excreted by a different route. It is likely that, as for the metabolism of other steroids, excretion into the bile is balanced by re-absorption in the intestine and some part is excreted with the faeces
Fludrocortisone acetate Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Nanjing Shizhou Biotechnology Co., Ltd | +86-15850508050 +86-15850508050 | sean.lv@synzest.com | China | 323 | 58 |
| Hangzhou ICH Biofarm Co., Ltd | +86-0571-28186870; +undefined8613073685410 | sales@ichemie.com | China | 998 | 58 |
| career henan chemical co | +86-0371-86658258 +8613203830695 | sales@coreychem.com | China | 29886 | 58 |
| Hubei Jusheng Technology Co.,Ltd. | 18871490254 | linda@hubeijusheng.com | CHINA | 28172 | 58 |
| Hubei xin bonus chemical co. LTD | 86-13657291602 | linda@hubeijusheng.com | CHINA | 22963 | 58 |
| Chongqing Chemdad Co., Ltd | +86-023-6139-8061 +86-86-13650506873 | sales@chemdad.com | China | 39894 | 58 |
| CONIER CHEM AND PHARMA LIMITED | +8618523575427 | sales@conier.com | China | 49374 | 58 |
| Hebei Mojin Biotechnology Co., Ltd | +86 13288715578 +8613288715578 | sales@hbmojin.com | China | 12829 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 32024 | 58 |
| Longyan Tianhua Biological Technology Co., Ltd | 0086 18039857276 18039857276 | CHINA | 2783 | 58 |
View Lastest Price from Fludrocortisone acetate manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2024-10-31 | Fludrocortisone acetate
514-36-3
|
US $29.00 / mg | 98.03% | 10g | TargetMol Chemicals Inc. | ||
 |
2023-11-01 | Fludrocortisone acetate
514-36-3
|
US $0.00-0.00 / g | 1g | 99% | 100kg | Hangzhou ICH Biofarm Co., Ltd | |
 |
2023-01-31 | Fludrocortisone Acetate
514-36-3
|
US $0.00 / KG | 1KG | 99% | 50000KG/month | Hebei Mojin Biotechnology Co., Ltd |
-
- Fludrocortisone acetate
514-36-3
- US $29.00 / mg
- 98.03%
- TargetMol Chemicals Inc.
-
- Fludrocortisone acetate
514-36-3
- US $0.00-0.00 / g
- 99%
- Hangzhou ICH Biofarm Co., Ltd
-
- Fludrocortisone Acetate
514-36-3
- US $0.00 / KG
- 99%
- Hebei Mojin Biotechnology Co., Ltd
514-36-3(Fludrocortisone acetate)Related Search:
1of4